- Home
- SEIC vs QGEN Comparison
SEIC vs QGEN Comparison
Compare SEIC & QGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SEIC
- QGEN
- Stock Information
- Founded
- SEIC 1968
- QGEN 1986
- Country
- SEIC United States
- QGEN Netherlands
- Employees
- SEIC N/A
- QGEN N/A
- Industry
- SEIC Investment Bankers/Brokers/Service
- QGEN Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- SEIC Finance
- QGEN Health Care
- Exchange
- SEIC Nasdaq
- QGEN Nasdaq
- Market Cap
- SEIC 10.6B
- QGEN 10.7B
- IPO Year
- SEIC N/A
- QGEN 1996
- Fundamental
- Price
- SEIC $82.91
- QGEN $43.42
- Analyst Decision
- SEIC Buy
- QGEN Buy
- Analyst Count
- SEIC 7
- QGEN 7
- Target Price
- SEIC $100.29
- QGEN $50.68
- AVG Volume (30 Days)
- SEIC 666.9K
- QGEN 1.1M
- Earning Date
- SEIC 10-22-2025
- QGEN 11-04-2025
- Dividend Yield
- SEIC 1.18%
- QGEN 3.51%
- EPS Growth
- SEIC 30.71
- QGEN 334.36
- EPS
- SEIC 5.43
- QGEN 1.85
- Revenue
- SEIC $2,246,646,000.00
- QGEN $2,070,781,000.00
- Revenue This Year
- SEIC $9.87
- QGEN $7.37
- Revenue Next Year
- SEIC $8.01
- QGEN $5.65
- P/E Ratio
- SEIC $15.28
- QGEN $23.25
- Revenue Growth
- SEIC 9.44
- QGEN 5.32
- 52 Week Low
- SEIC $64.66
- QGEN $37.63
- 52 Week High
- SEIC $93.96
- QGEN $51.88
- Technical
- Relative Strength Index (RSI)
- SEIC 51.09
- QGEN 29.66
- Support Level
- SEIC $80.59
- QGEN $43.26
- Resistance Level
- SEIC $82.84
- QGEN $47.39
- Average True Range (ATR)
- SEIC 1.48
- QGEN 1.09
- MACD
- SEIC 0.31
- QGEN -0.60
- Stochastic Oscillator
- SEIC 82.19
- QGEN 8.86
About SEIC SEI Investments Company
SEI Investments provides investment processing, management, and operations services to financial institutions, asset managers, asset owners, and financial advisors in four material segments: private banks, investment advisors, institutional investors, and investment managers. SEI also has a minority interest in LSV Asset Management, a value equity asset manager with about $87 billion in assets under management. As of December 2024, SEI (including LSV) manages, administers, or advises about $1.6 trillion in assets.
About QGEN Qiagen N.V.
Qiagen offers proprietary sample and assay technology to extract, purify, amplify, and interpret DNA, RNA, and proteins. The company's sales are split almost evenly between applications in life sciences and molecular diagnostics. Qiagen generates nearly 90% of its revenue from consumables with the balance coming from instrumentation and related services. The Americas account for the largest portion of the firm's revenue (52% of 2024 sales), followed by EMEA (33%), and the Asia-Pacific (15%).